SIScott Isom

Scott Isom

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Scott Isom has a total of 103 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association between oral ulcerative lesions, oral infections, and fever during the pre-engraftment phase after hematopoietic cell transplantation: results from the Orastem study

    by A. M. G. A. Laheij, J. E. Raber-Durlacher, B. Hasséus, M. C. Huysmans, S. J. M. van Leeuwen, K. Garming Legert, J. E. Johansson, S. Isom, D. M. Kline, M. D. Hazenberg, et al.

    Purpose: The percentage of cases with fever of unknown origin after hematopoietic cell transplantation (HCT) is high. An often overlooked clinical infection in HCT recipients may be chronic inflammation from the oral cavity. Therefore, the aim of the present study was to assess fever in the pre-engraftment phase after HCT and to examine the relationship between oral foci of infection before and in the first weeks after HCT and fever. Methods: Adult patients, scheduled for autologous or allogeneic HCT, were included in this prospective, observational multicenter cohort study. Oral health was determined pre-HCT. Following HCT conditioning, fever was registered daily; and oral mucositis and other oral side effects were registered three times weekly. Results: Data from 186 patients were available. The mean age was 53.0 years (± 12.9), and 55.4% were male. The most common malignancies were multiple myeloma, acute myeloid leukemia, and lymphoma. In total, 69.4% of the patients developed fever and 43.1% had an oral ulcerative lesion. After correction for age, site, conditioning regimen, diarrhea, vomiting, and duration of leukopenia, oral ulceration size remained significantly associated with fever, especially when fever was defined as ≥ 38.5°C. Pre-HCT chronic dental and oral conditions showed no association with post-HCT fever. Conclusion: Fever was common during the pre-engraftment phase after HCT and significantly associated with the extent of oral ulcerations. In contrast, pre-HCT dental and oral conditions showed no association with post-HCT fever, highlighting the specific role of mucosal injury in febrile episodes.

  • Open Access

    Longitudinal assessment and predictors of subjective taste change after hematopoietic cell transplantation (HCT)

    by Allan J. Hovan, Michael T. Brennan, Bengt Hasséus, Judith E. Raber-Durlacher, Marie-Charlotte Huysmans, Alexa M. G. A. Laheij, Stephanie J. M. van Leeuwen, Karin Garming Legert, Scott Isom, David M. Kline, et al.

    Purpose: The aims of this investigation within the Orastem study were to describe the prevalence of subjective taste change, levels of patient-reported distress associated with taste change, and factors predicting taste change after hematopoietic cell transplantation (HCT) with a particular focus on factors predictive of severe and/or persistent (present at 12 months) taste change. Methods: Altogether, 238 patients at five cancer centers were followed during HCT hospitalization and up to 12 months post-HCT. Patients with taste change were compared to non-affected patients with respect to gender, age, transplant type, previous chemotherapy, conditioning regimen(s), oral mucositis, pre-HCT salivary flow, oral hygiene status and, in allogeneic HCT recipients, chronic oral graft-versus-host disease (GVHD). Distress from taste change was also evaluated. Results: During hospitalization, taste change was reported by over one-third (81/238) of patients to an open question on oral symptoms; of these, 41% reported taste change as their worst/most bothersome oral symptom. To a specific question on distress due to taste change, 76% of all patients reported some level of distress. Taste change from previous chemotherapy and full intensity conditioning were risk factors for severe taste change during hospitalization. At three months, allogeneic transplant patients reported a higher rate of severe taste change compared to autologous transplant patients. Increased age predicted severe taste change at 6 and 12-month follow-up. At twelve months, 13.1% of patients reported distress from taste change. Conclusion: This study confirmed taste change as a common clinical complaint post-HCT. Taste change remained a significant issue for a small subset of patients at 12 months. Further research is required to develop effective preventive and management strategies for this common oral side-effect post-HCT.

  • Open Access

    Patient‐Reported Oral Symptoms and Their Impact on Well‐Being After Haematopoietic Cell Transplantation

    by Kristina Skallsjö, Michael T. Brennan, Bengt Hasséus, Jenny Öhman, Judith E. Raber‐Durlacher, Marie‐Charlotte D. N. J. M. Huysmans, Alexa M. G. A. Laheij, Stephanie J. M. van Leeuwen, Allan J. Hovan, Karin Garming Legert, et al.

    Objective: Oral complications may negatively influence outcomes of haematopoietic cell transplantation (HCT). A comprehensive view of oral symptoms and symptom burden post‐HCT is lacking. This study aimed to determine the prevalence, severity, and temporal relationships of oral symptoms and their impact on well‐being in the early post‐HCT phase. Effects of transplant type and conditioning intensity were evaluated. Methods: In this prospective multicentre observational study, adult HCT recipients were interviewed and completed questionnaires on oral symptoms and well‐being three times a week during hospitalisation early post‐HCT. Results: Of 194 patients, 177 (91.2%) reported oral symptoms. Dry mouth was the earliest and most common (80.9%) followed by oral pain (35.6%), thickening/swollen mucosa (33.0%), and taste changes (30.9%). Symptom frequency peaked on days 6 to 11 post‐HCT and caused significant burden: 59.3% experienced moderate to severe distress and 53.6% reported moderate to severe impact on well‐being. Symptom prevalence was highest among patients who received allogeneic HCT with MAC and those who underwent autologous HCT. Overall, MAC regimens were associated with earlier and more frequent symptoms, greater distress and higher impact on well‐being during days 0 to 11 post‐HCT compared to reduced/non‐myeloablative regimens. Conclusions: Oral symptoms are prevalent, burdensome and significantly impact well‐being early post‐HCT, underscoring the need for close monitoring and supportive oral care.

  • Open Access

    Subjective Oral Dryness following Hematopoietic Cell Transplantation: A Report from the Orastem Study

    by Marjolein S. Bulthuis, Stephanie J.M. van Leeuwen, Renske Z. Thomas, Lucky L.A. van Gennip, Heidi M. Whiteside, Scott Isom, David M. Kline, Alexa M.G.A. Laheij, Judith E. Raber-Durlacher, Bengt Hasséus, et al.


  • Re-induction therapy in adult patients with acute myeloid leukemia with ≤20 % blasts: A retrospective cohort study

    by Kavya K. Kannan, Paz Vellanki, Scott Isom, Bernard Tawfik, Allison Winter, Heidi D. Klepin, Leslie R. Ellis, Rupali Roy Bhave, Dianna Howard, Megan Manuel, et al.


  • Open Access

    A cross sectional study to compare cardiac structure and diastolic function in adolescents and young adults with youth-onset type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Study

    by Amy S. Shah, Scott Isom, Dana Dabelea, Ralph D’agostino, Lawrence M. Dolan, Lynne Wagenknecht, Giuseppina Imperatore, Sharon Saydah, Angela D. Liese, Jean M. Lawrence, et al.

    Aims: To compare left ventricular structure (LV) and diastolic function in young adults with youth- onset diabetes by type, determine the prevalence of abnormal diastolic function by diabetes type using published values from age similar healthy controls, and examine the risk factors associated with diastolic function.Methods: In a cross sectional analysis we compared LV structure and diastolic function from two dimensional echocardiogram in participants with type 1 (T1D) and type 2 diabetes (T2D) who participated in the SEARCH for Diabetes in Youth Study. Linear models were used to examine the risk factors associated with worse diastolic function.Results: Of 479 participants studied, 258 had T1D (mean age 21.2 ± 5.2 years, 60.5% non-Hispanic white, 53.9% female) and 221 had T2D (mean age 24.8 ± 4.3 years, 24.4% non-Hispanic white, 73.8% female). Median diabetes duration was 11.6 years. Participants with T2D had greater LV mass index and worse diastolic function that persisted after adjustment for differences in risk factors compared with participants with T1D (all p < 0.05). Abnormal diastolic function, quantified using healthy controls, was pronounced in both groups but greater in those with T2D than T1D (T2D: 57.7% vs T1D: 47.2%, respectively), p < 0.05. Risk factors associated with worse diastolic function included older age at diabetes diagnosis, female sex, higher BP, heart rate and HbA1c and longer diabetes duration.Conclusions: LV structure and diastolic function is worse in individuals with T2D compared to T1D. However, abnormal diastolic function in seen in both groups compared to published values from age similar healthy controls.


  • Efficacy of 10-day decitabine in acute myeloid leukemia

    by Ian M. Bouligny, Vivek Mehta, Scott Isom, Leslie R. Ellis, Rupali R. Bhave, Dianna S. Howard, Susan Lyerly, Megan Manuel, Sarah Dralle, Bayard L. Powell, et al.


  • Open Access

    Clinical profile at diagnosis with youth‐onset type 1 and type 2 diabetes in two pediatric diabetes registries: SEARCH (United States) and YDR (India)

    by Christine W. Hockett, Pradeep A. Praveen, Toan C. Ong, Anandakumar Amutha, Scott P. Isom, Elizabeth T. Jensen, Ralph B. D'Agostino, Richard F. Hamman, Elizabeth J. Mayer‐Davis, Jean M. Lawrence, et al.

    Background Over the last decades, diabetes in youth has increased in both India and the U.S., along with the burden of long‐term complications and healthcare costs. However, there are limited standardized population‐based data in contemporary youth cohorts for comparison of clinical and demographic characteristics of diabetes for both type 1 (T1D) and type 2 (T2D). Methods In partnership, we harmonized demographic and clinical data from the SEARCH for Diabetes in Youth (SEARCH) registry in the U.S. and the Registry of People with Diabetes with Youth Age at Onset (YDR) in India to the structure and terminology of the Observational Medical Outcomes Partnership Common Data Model. Data were from youth with T1D and T2D, aged <20 years and newly diagnosed between 2006 and 2010. We compared key characteristics across registries using chi‐squared tests and t‐tests. Results In total, there were 9,650 youth with T1D and 2,406 youth with T2D from 2006 to 2012. SEARCH youth were diagnosed at younger ages than YDR youth for T1D and T2D (10.0 vs. 10.5 y, p<0.001 and 14.7 vs. 16.1 y, p<0.001, respectively). For T2D, SEARCH had a higher proportion of females and significantly lower proportion of youth of high socioeconomic status compared to YDR. For T1D and T2D, SEARCH youth had higher BMI, lower blood pressure, and lower A1c compared to YDR youth. Conclusions These data offer insights into the demographic and clinical characteristics of diabetes in youth across the two countries. Further research is needed to better understand why these differences exist.


  • Open Access

    Diagnostic accuracy of stereotactic brain biopsy for intracranial neoplasia in dogs: Comparison of biopsy, surgical resection, and necropsy specimens

    by Yukitaka Kani, Thomas E. Cecere, Kevin Lahmers, Tanya LeRoith, Kurt L. Zimmerman, Scott Isom, Fang-Chi Hsu, Waldemar Debinksi, John L. Robertson, John H. Rossmeisl

    Background: Stereotactic brain biopsy (SBB) is a technique that allows for definitive diagnosis of brain lesions. Little information is available regarding the diagnostic utility of SBB in dogs with intracranial diseases. Objective: To investigate the diagnostic accuracy (DA) of SBB in dogs with brain tumors. Animals: Thirty-one client-owned dogs that underwent SBB followed by surgical resection or necropsy examinations. Methods: Retrospective observational study. Two pathologists blinded to SBB and reference standard diagnoses reviewed histologic specimens and typed and graded tumors according to World Health Organization and revised canine glioma classification criteria. Agreement between tumor type and grade from SBB were compared to reference standards and assessed using kappa statistics. Patient and technical factors associated with agreement also were examined. Results: Stereotactic brain biopsy specimens were obtained from 24 dogs with gliomas and 7 with meningiomas. Tumor type agreement between SBB and the reference standard was observed in 30/31 cases (κ = 0.95). Diagnostic concordance was perfect for meningiomas. Grade agreement among gliomas was observed in 18/23 cases (κ = 0.47). Stereotactic brain biopsy underrepresented the reference standard glioma grade in cases with disagreement. The DA of SBB was 81%, with agreement noted in 56/69 biopsy samples. Smaller tumors and fewer SBB specimens obtained were significantly associated with diagnostic discordance. Conclusions and Clinical Importance: The DA of SBB readily allows for the diagnosis of common brain tumors in dogs. Although glioma grade discordance was frequent, diagnoses obtained from SBB are sufficient to currently inform therapeutic decisions. Multiple SBB specimens should be collected to maximize DA.


  • Open Access

    Tacrolimus Levels and Correlation to Age and Weight Calculation

    by Mary Beth Seegars, Janet Tooze, Scott Isom, Brandi Anders, LeAnne Kennedy, Cesar Rodriguez